(1.26%) 5 127.79 points
(1.18%) 38 676 points
(1.99%) 16 156 points
(-0.15%) $77.99
(0.37%) $2.15
(0.06%) $2 310.10
(0.36%) $26.79
(0.09%) $966.20
(-0.34%) $0.929
(-1.09%) $10.87
(-0.16%) $0.797
(0.52%) $91.61
4 days till quarter result
(bmo 2024-05-09)
Expected move: +/- 0.00%
-2.56% $ 2.66
Live Chart Being Loaded With Signals
OncoCyte Corporation, a molecular diagnostics company, researches, develops, and commercializes proprietary laboratory-developed tests for the detection of cancer in the United States and internationally...
Stats | |
---|---|
Volumen de hoy | 15 346.00 |
Volumen promedio | 59 472.00 |
Capitalización de mercado | 35.55M |
EPS | $0 ( 2024-03-29 ) |
Próxima fecha de ganancias | ( $-0.820 ) 2024-05-09 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | -0.790 |
ATR14 | $0.0410 (1.52%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-04-11 | Broadwood Partners, L.p. | Buy | 2 420 000 | Common Stock, no par value |
2024-04-11 | Broadwood Partners, L.p. | Buy | 0 | Common Stock, no par value |
2024-04-15 | Broadwood Partners, L.p. | Sell | 0 | Series A Convertible Preferred Stock |
2024-04-11 | Riggs Josh | Buy | 3 390 | Common Stock, no par value |
2024-04-11 | Arno Andrew | Buy | 33 898 | Common Stock, no par value |
INSIDER POWER |
---|
37.39 |
Last 97 transactions |
Buy: 36 875 696 | Sell: 16 930 326 |
OncoCyte Corp Correlación
10 Correlaciones Más Positivas |
---|
10 Correlaciones Más Negativas |
---|
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
OncoCyte Corp Correlación - Moneda/Commodity
OncoCyte Corp Finanzas
Annual | 2023 |
Ingresos: | $1.50M |
Beneficio Bruto: | $501 000 (33.33 %) |
EPS: | $-3.63 |
FY | 2023 |
Ingresos: | $1.50M |
Beneficio Bruto: | $501 000 (33.33 %) |
EPS: | $-3.63 |
FY | 2022 |
Ingresos: | $958 000 |
Beneficio Bruto: | $-18 000.00 (-1.88 %) |
EPS: | $-13.26 |
FY | 2021 |
Ingresos: | $7.73M |
Beneficio Bruto: | $188 000 (2.43 %) |
EPS: | $-0.720 |
Financial Reports:
No articles found.
OncoCyte Corp
OncoCyte Corporation, a molecular diagnostics company, researches, develops, and commercializes proprietary laboratory-developed tests for the detection of cancer in the United States and internationally. The company offers DetermaRx, a molecular test for early-stage adenocarcinoma of the lung; and DetermaIO, a proprietary gene expression assay. It also provides biomarker discovery testing, assay design and development, and clinical trial support services, as well as various biomarker tests for pharmaceutical companies. The company has a collaboration agreement with Life Technologies Corporation to develop and collaborate in the commercialization of Oncomine Comprehensive Assay Plus and Determa IO assay for use with Ion Torrent Genexus integrated sequencer and purification system. OncoCyte Corporation was incorporated in 2009 and is based in Irvine, California.
Acerca de Señales en Vivo
Las señales en vivo presentadas en esta página ayudan a determinar cuándo COMPRAR o VENDER NA. Las señales tienen un retraso de más de 1 minuto; como todas las señales del mercado, existe la posibilidad de error o errores.
Las señales de trading en vivo no son definitivas y getagraph.com no asume ninguna responsabilidad por cualquier acción tomada sobre estas señales, como se describe en los Términos de Uso. Las señales se basan en una amplia gama de indicadores de análisis técnico